MAS1L and early-onset autosomal dominant Alzheimer disease: Side by side, it was reported in an Alzheimer disease rat model that the potential therapeutic strategy of diminazene ameliorates induced hippocampal ACE2/MasR activation with PI3K/Akt transduction endorsed many neuroprotective, anti-apoptotic, and anti-inflammatory effects [54].